CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $1.37B, above the global median of $1.18B
- PositionDebt-to-equity is 0.01×, lower than 95% of its Pharmaceutical Retailers peers (median 0.72×)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.91%Above 5Y avg (1.93%)
Annual Rate
JPY 96.00Paid semi-annual
Payout Ratio
35.4%Sustainable
Next Ex-Dividend
Nov 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
214.48BJPY1.37B · vs all stocks (USD)
Trailing P/E
12.55xvs Pharmaceutical Retailers peers
Revenue (TTM)
497.13BJPY3.17B · vs all stocks (USD)
Profit Margin
3.42%vs Pharmaceutical Retailers peers
Beta
0.1450xvs all stocks
52-Week Change
-0.60%vs all stocks
Forward Annual Dividend Yield
2.91%vs all stocks
Market Capitalization
214.48BJPY1.37B · vs all stocks (USD)
Enterprise Value
177.45BJPY1.13B · vs all stocks (USD)
Trailing P/E
12.55xvs Pharmaceutical Retailers peers
PEG Ratio
6.88xPrice to Sales (TTM)
0.4288xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
1.38xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.3570xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
5.81xvs Pharmaceutical Retailers peers
Profit Margin
3.42%vs Pharmaceutical Retailers peers
Operating Margin
5.49%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
6.09%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
11.44%vs Pharmaceutical Retailers peers
Revenue (TTM)
497.13BJPY3.17B · vs all stocks (USD)
Revenue per Share (TTM)
7.70KJPYUpdated Sep 21, 2026Quarterly Revenue Growth
11.30%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
126.95BJPY809.32M · vs all stocks (USD)
EBITDA (TTM)
31.69BJPY202.01M · vs all stocks (USD)
Net Income (TTM)
16.99BJPY108.31M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.30%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
25.44BJPY162.15M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
4.21BJPY26.82M · vs all stocks (USD)
Forward Annual Dividend Rate
96.00JPYUpdated Sep 21, 2026Forward Annual Dividend Yield
2.91%vs all stocks
Trailing Annual Dividend Rate
93.00JPYUpdated Sep 21, 2026Trailing Annual Dividend Yield
2.82%vs all stocks
5-Year Average Dividend Yield
1.93%vs all stocks
Payout Ratio
35.36%vs Pharmaceutical Retailers peers
Revenue
457.09BJPYFY2025 · May 31, 2025Cost of Goods Sold
337.87BJPYFY2025 · May 31, 2025Gross Profit
119.22BJPYFY2025 · May 31, 2025Operating Income
22.63BJPY144.26M · vs all stocks (USD)
Pre-tax Income
21.99BJPYFY2025 · May 31, 2025Income Tax Expense
6.30BJPYFY2025 · May 31, 2025Net Income
15.69BJPYFY2025 · May 31, 2025EBIT
22.63BJPYFY2025 · May 31, 2025EBITDA (Income Statement)
29.73BJPYFY2025 · May 31, 2025Other Operating Expenses
32.42BJPYFY2025 · May 31, 2025Non-operating Interest Income
123.00MJPYFY2025 · May 31, 2025EPS (Basic)
242.82JPYFY2025 · May 31, 2025EPS (Diluted)
242.82JPYFY2025 · May 31, 2025Basic Shares Outstanding
64.60MSharesFY2025 · May 31, 2025Diluted Shares Outstanding
64.60MSharesFY2025 · May 31, 2025Minority Interests (P&L)
0.00JPYFY2025 · May 31, 2025Preferred Stock Dividends
0.00JPYFY2025 · May 31, 2025Operating Cash Flow
17.97BJPYFY2025 · May 31, 2025Free Cash Flow
443.00MJPYFY2025 · May 31, 2025Cash & Cash Equivalents (End of Period)
37.35BJPYFY2025 · May 31, 2025Starting Profit (CF Statement)
21.99BJPYFY2025 · May 31, 2025Other Non-cash Items
1.75BJPYFY2025 · May 31, 2025Change in Accounts Receivable (CF)
-2.08BJPYFY2025 · May 31, 2025Change in Other Assets/Liabilities
-3.69BJPYFY2025 · May 31, 2025Capital Expenditures
-17.52BJPYFY2025 · May 31, 2025Net Intangibles (CF)
-129.00MJPYFY2025 · May 31, 2025Sale of Investments
3.00MJPYFY2025 · May 31, 2025Other Investing Activity
-3.67BJPYFY2025 · May 31, 2025Net Investing Cash Flow
-21.19BJPYFY2025 · May 31, 2025Common Stock Repurchase
0.00JPYFY2025 · May 31, 2025Common Dividends Paid
-4.57BJPYFY2025 · May 31, 2025Other Financing Charges
-15.00MJPYFY2025 · May 31, 2025Net Financing Cash Flow
-3.39BJPYFY2025 · May 31, 2025Shares Outstanding
64.60MSharesUpdated Sep 21, 2026Float Shares
24.87MSharesUpdated Sep 21, 2026% Held by Insiders
58.83%vs all stocks
% Held by Institutions
20.72%vs all stocks
Total Cash (MRQ)
37.10BJPY236.50M · vs all stocks (USD)
Total Cash per Share (MRQ)
574.27JPYUpdated Sep 21, 2026Total Debt (MRQ)
1.36BJPY8.67M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0088xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.29xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
2.39KJPYUpdated Sep 21, 2026Total Assets
236.56BJPY1.51B · vs all stocks (USD)
Total Current Assets
112.04BJPYFY2025 · May 31, 2025Total Liabilities
93.84BJPYFY2025 · May 31, 2025Total Non-current Assets
124.52BJPYFY2025 · May 31, 2025Total Non-current Liabilities
9.17BJPYFY2025 · May 31, 2025Total Current Liabilities
84.67BJPYFY2025 · May 31, 2025Cash & Cash Equivalents
37.75BJPYFY2025 · May 31, 2025Accounts Receivable
17.51BJPYFY2025 · May 31, 2025Inventory
45.80BJPYFY2025 · May 31, 2025Accounts Payable
59.76BJPYFY2025 · May 31, 2025Other Current Liabilities
15.12BJPYFY2025 · May 31, 2025Other Non-current Liabilities
1.50BJPYFY2025 · May 31, 2025Common Stock (Book)
1.00BJPYFY2025 · May 31, 2025Retained Earnings
140.13BJPYFY2025 · May 31, 2025Total Shareholders' Equity
142.72BJPY909.83M · vs all stocks (USD)
Treasury Stock
2.71BJPYFY2025 · May 31, 202552-Week Low
3.09KJPYUpdated Sep 21, 202652-Week High
3.56KJPYUpdated Sep 21, 202652-Week Change
-0.60%vs all stocks
Beta
0.1450xvs all stocks
50-Day MA
3.36KJPYUpdated Sep 21, 2026200-Day MA
3.30KJPYUpdated Sep 21, 2026Avg 10-Day Volume
60.59KSharesUpdated Sep 21, 2026Avg 30-Day Volume
68.99KSharesUpdated Sep 21, 2026Diluted EPS (TTM)
263.01JPYUpdated Sep 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0.01×, lower than 95% of its Pharmaceutical Retailers peers (median 0.72×)Notable
Debt-to-equity: 0.01Industry median: 0.72Industry P5: 0.18Peers compared: 21.00
Financial Health
Altman Z-Score 4.59: safe zoneNotable
Altman Z-Score: 4.59
High earnings qualityNotable
Earnings Quality Score: 0.70
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $1.37B, above the global median of $1.18BNotable
Market cap (USD): 1,367,285,469.608Global Median: 1,180,223,658.953
Revenue is $3.17B, above the global median of $548.88MNotable
Revenue (USD): 3,169,141,375.327Global Median: 548,883,780.48
Levered free cash flow is $26.82M, above the global median of $18.73MNotable
Levered free cash flow (USD): 26,818,406.673Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
United Electronics Co.
Tier 1FlowUnit ReplicationInterfaceRisk
Kidswant Children Products Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
E-Mart Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Seria Co. Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Savers Value Village Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Winmark Corporation
Tier 1FlowUnit ReplicationProductionInterface
Napco Security Technologies, Inc.
Tier 1FlowUnit ReplicationProductionRule
Laobaixing Pharmacy Chain Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Com7 Public Company Limited
Tier 1FlowUnit ReplicationInterfaceAttention
Hunan Heshun Petroleum Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Fabrinet
3 interpretationsHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income Growth
Garmin Ltd.
3 interpretationsHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income Growth
Inter Parfums, Inc.
3 interpretationsHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income Growth